Cyclacel Pharmaceuticals Earning Date (CYCC)

USA |NASDAQ |USD

CYCC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 23, 2022 Dec 2021 $-0.65 $-0.54 $-1.34
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 23, 2022 Dec 2021 $0.00 $0.00 $0.00

Cyclacel Pharmaceuticals's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 2021.

CYCC Earnings Date & History Chart

CYCC Earnings & Revenue Forecast

CYCC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 2 $-0.63 $-0.69 $-0.58
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $-2.90 $-3.21 $-2.43

CYCC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 1 / 0 $-0.70 $-0.70 $-0.70
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $-2.93 $-2.92 $-2.93

CYCC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $0.00 $0.00 $0.00

CYCC Earnings Date & Revenue History

CYCC Earnings History

|
Show More
Show More

CYCC Revenue History

|
Show More
Show More

Cyclacel Pharmaceuticals Next Earnings Date & Report

CYCC Next Earnings Date & Report Preview: Dec 2021 (FQ)

CYCC's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 3 analysts, the average EPS estimation for Cyclacel Pharmaceuticals's next quarterly earnings is $-0.65, with a low EPS estimation of $-0.71, and a high estimation of $-0.62.

Over the last 1 month, EPS estimates have seen 3 upward revisions and 0 downward. The EPS 1 month trend is $-0.68, the last 2 month trend is $-0.68, and the 3 month trend is $-0.68.

Based on 2 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Cyclacel Pharmaceuticals Previous Earnings Dates & Reports

CYCC Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Cyclacel Pharmaceuticals's previous earnings date was Nov 10, 2021 for its fiscal quarter ended Sep 30, 2021.

CYCC's earnings per share (EPS) was $-0.54, beating the consensus analysts forecast of $-0.70 by 22.86%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -3.57%, and lower than the same period a year before (Sep 2020) by 14.89%.

Revenues were $0.00.

The company reported a net income of $-4.99M.

Free cash flow for the quarter was $-6.22M , compared to $-4.15M last quarter and $-2.18M a year before.

CYCC Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cyclacel Pharmaceuticals's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

CYCC's earnings per share (EPS) was $-3.87, missing the consensus analysts forecast of $-2.56 by 51.17% , and higher than the previous year's EPS (Dec 2019) by -61.30%.

Revenues were $5.88K.

The company reported a net income of $-8.45M.

Cyclacel Pharmaceuticals reported a free cash flow of $-8.03M for its fiscal year, compared to $-9.46M a year ago.

The company ended the fiscal year with $1.06M in total debt, a decrease of -11.25% compared to the previous year.